Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

BIZARRE: Arrowhead org | Mind Blowing Facts

The Helldivers 2 and Warhammer 40K crossover is getting a full reveal on July 30: "Update your calendar accordingly"

Tune in for some grimdarkness

GamesRadar

"How Ubisoft and Embracer leadership aren't in prison absolutely eludes me": Helldivers 2 studio QA manager laments "darkest timeline" as layoffs hurt thousands

The bloodbath gets thicker

GamesRadar

Helldivers 2 dev cracks down on 'suspicious super credit activity', though it would help if earning premium currency wasn't so boring to begin with

"We're starting to implement changes that will tackle issues like this."

PC Gamer

From analysis to the latest developments in health,
read the most diverse news in one place.

Helldivers 2 targets Super Credit cheaters with "radically improved" tools, but not everyone's on board with Arrowhead's announcement

A win for the community or for Arrowhead?

GamesRadar

Helldivers 2's next warbond is delayed, as Arrowhead says it 'needs more time to cook' following the shooter's massive progression rework

"We will provide more information as it nears completion."

PC Gamer

Next Helldivers 2 Warbond "needs more time to cook," Arrowhead says, so it's getting indefinitely delayed

Most fans are just glad Arrowhead let them know

GamesRadar

Helldivers 2 overhauls Major Orders with Galactic Campaigns, adds a new biome, buffs Exo Suits, and much more in a massive patch

Arrowhead is "committed to making the necessary upgrades to keep you in the fight"

GamesRadar

Read news from The Economist, FT, and more,
with one subscription

Helldivers 2 will evolve major orders into galactic war campaigns later this month, with huge changes to mission distribution and Super Destroyers also in the works

Better ship customisation is also coming to Arrowhead's sci-fi shooter.

PC Gamer

Arrowhead Pharmaceuticals Lines Up SHASTA Readout as REDEMPLO Launch Gains Traction

Arrowhead Pharmaceuticals (NASDAQ:ARWR) executives outlined upcoming clinical catalysts, early commercial trends and pipeline priorities during a Jefferies fireside chat, with Chief Medical Officer James Hamilton emphasizing that the company remains focused exclusively on siRNA therapeutics through

MarketBeat

Helldivers 2 announces huge updates with "the next evolution of Major Orders," massive progression changes, and new rewards — oh, and fixes I've been praying for, too

Helldivers 2 dev Arrowhead has announced some massive updates coming for the game that take aim at some of the community's biggest problems with it.

Windows Central

Helldivers 2 promises "the next evolution of Major Orders," an increased level cap, new missions and more in huge progression overhaul

Arrowhead's making some big changes

GamesRadar

Arrowhead takes another swing at Helldivers 2's long-standing performance issues with a patch to "help you stay on target when the battlefield gets chaotic"

"Super Earth's finest engineers have been hard at work"

GamesRadar

Helldivers 2 begins the long march back into the community's good books with a technical patch that represents the 'opening salvo' in a battle for better performance

Upscaling support, advanced visual optimisation, and more on the way.

PC Gamer

The next Helldivers 2 Legendary Warbond is Warhammer 40,000, which is kind of perfect

Game recognizes game

GamesRadar

Get all your
news in one place.

100's of premium titles.
One news app.

GamesRadar

Helldivers 2 recruits PlayStation PC port studio for "opening salvo in an ongoing campaign to improve performance"

Fixing unstable foundations

MarketBeat

Arrowhead Pharmaceuticals Eyes Q3 SHASTA Data as REDEMPLO Approvals Build Momentum

Arrowhead Pharmaceuticals (NASDAQ:ARWR) executives said the company is entering a key period marked by new regulatory approvals, early commercial progress for REDEMPLO and upcoming Phase 3 data in severe hypertriglyceridemia, during a fireside chat at RBC Capital Markets’ 2026 Global Healthcare Conf

MarketBeat

Arrowhead Pharmaceuticals Eyes $4B REDEMPLO Opportunity as RNAi Pipeline Readouts Near

Arrowhead Pharmaceuticals (NASDAQ:ARWR) is moving into a more commercial phase while continuing to expand its RNA interference pipeline, Chief Executive Officer Chris Anzalone said during a presentation with BofA pharma and biotech analyst Jason Gerberry at the BofA Annual Healthcare Conference. An

Destructoid

Helldivers 2 hits mostly negative on Steam as player frustrations grow: ‘You had lightning in a bottle and decided to pry the lid off yourself’

Not a great time for Helldivers 2 fans.

Get all your
news in one place.

100's of premium titles.
One news app.

GamesRadar

Helldivers 2's recent Steam reviews drop to Mostly Negative as players accuse Arrowhead of favoring new Warbonds over fixing issues: "Making the game unbearable"

There's been a rash of bad feedback lately

GamesRadar

"Live service is tricky as hell": Helldivers 2 boss says updates are "not an exact science" because the "community changes" constantly

After two years, Arrowhead knows a thing or three about patches

PC Gamer

Helldivers 2 finally buffs mechs with double durability, and in unrelated news, Arrowhead is selling new mechs for $10

Patch 6.2.2 is live now.

GamesRadar

Helldivers 2 lead promises "meaningful changes" after "painful to read" criticism of Arrowhead and the state of the game fills uncensored Reddit AMA

"Thank you to everyone who participated constructively, especially when you were angry"

Destructoid

How to complete Destroy Exospire in Helldivers 2

Take them down!

Dot Esports

Helldivers 2 lays out its first official content roadmap through June

New enemies of Democracy are approaching!

GamesRadar

Helldivers 2 gives in after 2 years, releases first roadmap for Machinery of Oppression: new enemies, biomes, missions, vehicles, and more as Arrowhead once again says "this is just beginning"

Finally, we can see what's coming

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.